Summary:

- The article discusses a study that found DNA contamination in various FDA-approved drugs and medical devices, raising concerns about the safety and quality control of these products.

- The FDA has responded to the study, acknowledging the potential issue of DNA contamination and stating that they are investigating the matter further to determine the extent and impact of the problem.

- The article highlights the importance of rigorous quality control and regulatory oversight in the pharmaceutical and medical device industries to ensure the safety and efficacy of the products used by patients.